An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment
Clinical trial NCT04087252 · UNKNOWN
Trial details
- NCT number
- NCT04087252
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2021-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.